Anne Li 1/1/17 The National Institute for Health and Care Excellence (NICE) has published draft guidance stating that the breast cancer drug trastuzumab emtansine (also known as Kadcyla) will not be made routinely available through the NHS.…...
Dr. Kanaga Sabapathy Joins Asian Fund for Cancer Research Scientific Advisory Board
The Asian Fund for Cancer Research (AFCR) today announced the addition of Professor Kanaga Sabapathy, Head of the Division of Cellular & Molecular Research and Director of Planning & Strategy at The National Cancer Center Singapore, to its Scientific Advisory Board. Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular…...